Advances in Rabies Vaccination

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".

Deadline for manuscript submissions: 31 August 2026 | Viewed by 61

Special Issue Editors


E-Mail Website
Guest Editor
State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing 100071, China
Interests: rabies virus; epidemiology; humoral immunity
College of Animal Science and Technology College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China
Interests: epidemiology; pathogenesis and new vaccine development for rabies and other zoonotic diseases and pet diseases
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Veterinary Medical Diagnostic Laboratory (VMDL), University of Missouri, Columbia, MO, USA
Interests: rabies diagnostics; rabies vaccines and biologics; clinical laboratory test development/validation and quality assurance; emerging infectious diseases

Special Issue Information

Dear Colleagues,

We are pleased to invite you to contribute to this Special Issue, titled "Advances in Rabies Vaccination." Rabies remains one of the most lethal zoonotic diseases, causing an estimated 59,000 human deaths annually. Recent advancements in reverse genetics, structural vaccinology, mRNA vaccine platforms, and monoclonal antibody cocktails are reshaping our arsenal against the rabies virus and other lyssaviruses. Additionally, novel biologics for post-exposure prophylaxis, thermostable oral vaccines for wildlife reservoirs, and machine-learning-assisted risk assessment tools are extending protection to previously unreachable populations.

Aligned with the scope of the journal Vaccines, this Special Issue will cover immunology, next-generation vaccine design, adjuvant and delivery innovations, immunization strategies, epidemiological modeling, and regulatory considerations. Our goal is to assemble original research and reviews that together provide a comprehensive overview of current progress and future directions in rabies prevention and control.

Research areas of interest include the following:

- Immunological processes associated with rabies vaccines and correlates of protection;

- Rabies vaccine platforms (mRNA, recombinant, adjuvanted vaccines, etc.);

- Therapeutic monoclonal antibodies and passive immunization;

- Thermostable and oral baits for wildlife and dog vaccination campaigns;

- Studies on rabies transmission dynamics and vaccine coverage;

- Optimization of post-exposure prophylaxis in resource-limited settings;

- Innovative delivery systems (thermostable vaccines, oral baits, microneedle patches).

We look forward to receiving your contributions.

Dr. Ye Feng
Dr. Ming Zhou
Dr. Susan M. Moore
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • rabies immunity
  • rabies vaccines
  • immunological mechanisms
  • correlates of protection
  • monoclonal antibodies
  • oral vaccination
  • vaccine delivery systems
  • post-exposure prophylaxis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop